The recent reduction in mortality from bleeding oesophageal varices is primarily observed from Days 1 to 5

Liver International

Volumn 30, Issue 3, 2010, Pages 455-462

  Hobolth, Lise ^a   Krag, Aleksander ^a   Bendtsen, Flemming ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Baveno IV; Mortality; Oesophageal varices; Portalhypertension; Rebleeding

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCERYL TRINITRATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SOMATOSTATIN; TERLIPRESSIN; VASOPRESSIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTERY LIGATION; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; RETROSPECTIVE STUDY; SCLEROTHERAPY; TREATMENT RESPONSE;

ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTATICS; HUMANS; LIGATION; MALE; MIDDLE AGED; RECURRENCE; SCLEROTHERAPY; SURVIVAL RATE; VASOCONSTRICTOR AGENTS;

EID: 77950606404     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02169.x     Document Type: Article

References (31)

1. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981, 80:800-9.
2. Gotzsche PC, Hrobjartsson A. Somatostatin analogues for acute bleeding oesophageal varices. 2008;CD000193
3. Ioannou GN, Doust J, Rockey DC. Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther 2003, 17:53-64.
4. Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. The Copenhagen esophageal varices sclerotherapy project. N Engl J Med 1984, 311:1594-600.
5. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995, 123:280-7.
6. Soares-Weiser K, Brezis M, Tur-Kaspa R. Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials. Scand J Gastroenterol 2003, 38:193-200.
7. Bernard B, Grange JD, Khac EN. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999, 29:1655-61.
8. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005, 41:386-400.
9. Carbonell N, Pauwels A, Serfaty L. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004, 40:652-9.
10. Chalasani N, Kahi C, Francois F. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003, 98:653-9.
11. McCormick PA, O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001, 49:682-5.
12. Stokkeland K, Brandt L, Ekbom A, Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969-2002. Hepatology 2006, 43:500-5.
13. Thomopoulos K, Theocharis G, Mimidis K. Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of short- and long-term mortality. Dig Liver Dis 2006, 38:899-904.
14. D'Amico G, de Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003, 38:599-612.
15. Seo YS, Kim YH, Ahn SH. Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis. J Korean Med Sci 2008, 23:635-43.
16. Jamal MM, Samarasena JB, Hashemzadeh M. Decreasing in-hospital mortality for oesophageal variceal hemorrhage in the USA. Eur J Gastroenterol Hepatol 2008, 20:947-55.
17. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial. PROVA Study Group Hepatol 1991, 14:1016-24.
18. Gimson AE, Ramage JK, Panos MZ. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet 1993, 342:391-4.
19. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005, 43:167-76.
20. Castaneda B, Morales J, Lionetti R. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats. Hepatology 2001, 33:821-5.
21. Thabut D, D'Amico G, Tan P. Diagnostic performance of Baveno II/III and Baveno IV criteria in cirrhotic patients with gastrointestinal bleeding: analysis of the F7 liver - 1288 study population. Hepatology 2008, 48:625A.
22. Campbell SE, Campbell MK, Grimshaw JM, Walker AE. A systematic review of discharge coding accuracy. J Public Health Med 2001, 23:205-11.
23. Levacher S, Letoumelin P, Pateron D. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995, 346:865-8.
24. Colomo A, Hernandez-Gea V, Muniz-Diaz E. Transfusion strategies in patients with cirrhosis and acute gastrointestinal bleeding. Hepatology 2008, 48:413A.
25. Fernandez J, Ruiz del AL, Gomez C. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 2006, 131:1049-56.
26. Cales P, Lacave N, Silvain C. Prospective study on the application of the Baveno II consensus conference criteria in patients with cirrhosis and gastrointestinal bleeding. J Hepatol 2000, 33:738-41.
27. Duvnjak M, Barsic N, Tomasic V. Adjusted blood requirement index as indicator of failure to control acute variceal bleeding. Croat Med J 2006, 47:398-403.
28. Banares R, Albillos A, Rincon D. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002, 35:609-15.
29. Hou MC, Lin HC, Liu TT. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 2004, 39:746-53.
30. Hegnhoj J, Andersen JR, Jarlov JO, Bendtsen F, Rasmussen HS. Bacteriaemia after injection sclerotherapy of oesophageal varices. Liver 1988, 8:167-71.
31. Schuman BM, Beckman JW, Tedesco FJ, Griffin JW, Assad RT. Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol 1987, 82:823-30.